Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Response to Erythropoietin Treatment in Cancer Related Anemia Patients Receiving Chemotherapy

NCT01736215 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd.,Thailand as lead sponsor.

NCT NCT01736215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Response to Erythropoietin Treatment in Cancer Related Anemia Patients Receiving Chemotherapy
Lead sponsor
Janssen-Cilag Ltd.,Thailand
Phase
Observational
Overall status
Terminated
Start date
November 30, 2010
Completion date
February 29, 2012
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anemia - cancer related